DRUG

Ruxolitinib

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for Ruxolitinib

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
JAK2 poor prognosis 0.230 Mid reproduces known none

Clinical trials

200 registered trials for Ruxolitinib

Source: ClinicalTrials.gov